Benzinga's Top #PreMarket Gainers

Medical Action Industries

shares jumped 94.77% to $13.77 in pre-market trading after Owens & Minor

announced its plans to buy Medical Action Industries for $13.80 per share in cash. Aerie Pharmaceuticals

shares gained 28.39% to $27.00 in pre-market trading following the announcement that Roclatan phase 2b results have met all clinical endpoints. INSYS Therapeutics

shares jumped 4.34% to $30.27 in pre-market trading after the company confirmed receiving orphan drug designation for its pharmaceutical cannabidiol for epilepsy. Halozyme Therapeutics

shares gained 3.43% to $10.34 in pre-market trading after the company announced that the commercial launch of Roche's MabThera SC has triggered a $5 million milestone payment.